Mucosa-associated invariant T (MAIT) cells are "innate" T cells that express an invariant T-cell receptor α-chain restricted by the nonclassical MHC class I molecule MHC-related protein 1 (MR1). A recent discovery that MR1 presents vitamin B metabolites, presumably from pathogenic and/or commensal bacteria, distinguishes MAIT cells from peptide-or lipid-recognizing αβ T cells in the immune system. MAIT cells are activated by a wide variety of bacterial strains in vitro, but their role in defense against infectious assaults in vivo remains largely unknown. To investigate how MAIT cells contribute to mucosal immunity in vivo, we used a murine model of pulmonary infection by using the live vaccine strain (LVS) of Francisella tularensis. In the early acute phase of infection, MAIT cells expanded robustly in the lungs, where they preferentially accumulated after reaching their peak expansion in the late phase of infection. Throughout the course of infection, MAIT cells produced the critical cytokines IFN-γ, TNF-α, and IL-17A. Mechanistic studies showed that MAIT cells required both MR1 and IL-12 40 kDa subunit (IL-12p40) signals from infected antigen presenting cells to control F. tularensis LVS intracellular growth. Importantly, pulmonary F. tularensis LVS infection of MR1-deficient (MR1
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tularemia | respiratory infection F or intracellular bacteria, T-cell mediated immune responses are paramount for control of primary infection and adaptive secondary responses. However, conventional T cells must rely upon the innate immune system to initially detect a pathogen, requiring time for activation and expansion before they can control pathogen growth. This lag in the generation of adaptive immune responses is a critical time for the pathogen and the host.
Several unconventional T-cell subsets exist that can act during this critical lag time. These populations include certain types of γδ T cells, invariant natural killer (NK) T (iNKT) cells, and M3-restricted T cells. Collectively termed "innate T cells," they recognize "molecular patterns" and have the capacity to immediately express effector functions-both features that allow them to mount responses earlier than conventional T cells (1) . Correspondingly, both M3-restricted and iNKT cells exhibit extremely rapid response kinetics during infections in vivo, peaking in numbers and elaborating effector functions before conventional T-cell responses (2) (3) (4) (5) .
Mucosa-associated invariant T (MAIT) cells are a recently identified T-cell subset that also belongs to this class of innate T cells. MAIT cells express an evolutionarily conserved T-cell receptor (TCR) α-chain that is the product of a canonical Vα19-Jα33 rearrangement in mice and Vα7.2-Jα33 in humans. Biochemical and genetic studies have shown that MHC-related protein 1 (MR1) presents antigen for MAIT cell activation, and is necessary for their in vivo development (6) (7) (8) (9) (10) (11) (12) . The strong evolutionary conservation of MR1 across mammalian species indicates that MAIT cells likely have an important physiological role in host immune responses (13, 14) . Interestingly, MR1 possesses a unique antigen-binding cleft that presents vitamin B metabolites (15, 16) . Because vitamin B biosynthesis pathways are unique to bacteria and yeast, MAIT cells sense infection through the recognition of a novel class of conserved microbial ligands.
Several in vitro studies have demonstrated that MAIT cells have the capacity to respond to a wide variety of pathogens (12, (17) (18) (19) , although studies examining the in vivo role of MAIT cells in microbial defense have thus far been limited (17, 19, 20) . The rapid overgrowth of Klebsiella pneumoniae in MR1-deficient mice, which lack murine MAIT cells, suggests MAIT cells may have an early innate role in bacterial defense (20) . In humans, MAIT cells were present in the lungs of patients infected with the pulmonary pathogen Mycobacterium tuberculosis, whereas MR1-deficient mice exhibited transiently elevated lung bacterial burdens following aerosol Mycobacterium bovis bacillus CalmetteGuérin infection (17) (18) (19) . These studies indicated that MAIT cells are likely important contributors to defense against respiratory infections.
Despite a model favoring a critical, evolutionarily conserved role for MAIT cells in microbial immunity, critical questions remain regarding their activities and influence on the outcome of in vivo mucosal infections (21) . Indeed, although MAIT cells are proposed to act as innate T cells with the potential to bridge innate and adaptive immune immunity, their in vivo response kinetics and role in facilitating adaptive immune responses are unknown. To address these questions in vivo, we used a murine model of pulmonary infection that used Francisella tularensis live vaccine strain (LVS). F. tularensis is a Gram-negative, facultative Significance Mucosa-associated invariant T (MAIT) cells are an innate T-cell subset uniquely activated by microbe-derived vitamin B metabolites. Thus far, little is known about MAIT cell contributions to defense against pathogens in vivo. Using murine respiratory tularemia as a model of mucosal infection, we show that MAIT cells are required for the prompt initiation of immune responses in the lungs. Surprisingly, MAIT cells also actively contributed to immunity throughout the later stages of infection. Thus, MAIT cells are a unique T-cell subset with wide-ranging activities that may be harnessed to improve future vaccines and adjuvants used at mucosal surfaces. intracellular bacterium and the causative agent of tularemia. Classified as a Category A bioterrorism agent, inhalation of virulent strains of F. tularensis rapidly progresses to acute lethal disease in as many as 60% of untreated patients (22) . The F .tularensis LVS has shown potential as a protective vaccine in animal studies, and is currently an investigational product in the United States (23) . Intranasal (i.n.) infection of mice with sublethal doses of F. tularensis LVS offers a convenient model to perform a detailed study of mucosal immune responses. Optimal defense against primary LVS pulmonary infection requires conventional CD4 + and/or CD8 + T cells for clearance of the bacterium, although a distinct lag time exists before these adaptive immune responses are operational. This lag in the generation of adaptive immunity represents a critical window when innate T cells, including MAIT cells, are proposed to bridge immune responses.
Here we took advantage of the murine model of sublethal F. tularensis LVS pulmonary infection to investigate the kinetics and function of murine MAIT cell responses in the lungs in vivo. In the early acute phase of infection, MAIT cells expanded robustly in the lungs. After reaching their peak expansion in the late phase of infection, MAIT cells remained a prominent presence in the lungs. MAIT cells contributed to mucosal immunity by actively producing antibacterial cytokines throughout infection. The potency of MAIT cell activities was revealed by their ability to provide long-term control of an in vivo sublethal LVS pulmonary infection in the absence of adaptive CD4 + and CD8 + T cells. Moreover, comparative studies between WT C57BL/6 and MR1-deficient (MR1 −/− ) mice revealed a previously unrecognized role for MAIT cells in facilitating the early production of proinflammatory cytokines, and the timely recruitment of activated, IFN-γ-producing CD4 + and CD8 + T cells to the lungs. Overall, this report provides evidence that MAIT cells act early to initiate immunity, but, unlike our current understanding of other innate TCRβ + T cells, MAIT cells actively contribute to pulmonary immune responses that extend into the later phases of infection.
Results

MAIT Cells Are a Large CD4
−
CD8
− T-Cell Population in the Lungs During Primary Murine F. tularensis LVS i.n. Infection. Despite abundant in vitro evidence of MAIT cell activation by microbial infections, little is known about how MAIT cells respond to infections in vivo. For this reason, we sought to identify a murine mucosal infection model in which in vivo MAIT cell responses could be examined in detail. As the majority of murine MAIT cells are CD4 − CD8 − "double negative" (DN) T cells (10) , and previous evidence has revealed a robust population of DN T cells in the lungs of WT C57BL/6 mice during primary sublethal LVS i.n. infection (24), we first examined this lung DN T cell population for the presence of MAIT cells.
Currently there are no definitive antibodies that distinguish murine MAIT cells from other T cells, but MAIT cells can be identified by their expression of the Vα19-Jα33 invariant TCR α-chain. Therefore, we used a two-step approach that combined (i) FACS to purify the TCRβ + DN T cell population from the lungs of WT C57BL/6 mice during sublethal LVS i.n. infection and (ii) quantitative real time (RT)-PCR (qPCR) to assess the expression of MAIT cell Vα19-Jα33 invariant α-chain transcripts in the highly purified lung TCRβ + DN T cell population. Results showed that, in the early acute stage (day 7) of i.n. infection of LVS, TCRβ + DN T cells were a relatively small lung population (Fig. 1A) , but Vα19-Jα33 transcripts were readily detected (Fig.  1B) . Interestingly, in the late clearance phase (day 14) of infection, the lung TCRβ + DN T cell population had expanded significantly (Fig. 1A) , and was highly enriched for Vα19-Jα33 transcripts (Fig. 1B) . Because MAIT cells are known to preferentially associate with TCR β-chains containing Vβ6 or Vβ8 segments (10, 25), we further examined lung DN T cells for surface expression of these TCR β-chains. Approximately 79% of the lung CD3 + DN T cells on day 14 after LVS infection expressed either Vβ6 or Vβ8 (Fig. 1C) , compared with 25% to 45% of conventional CD4 + and CD8 + T cells in the same mice. These data collectively demonstrate that TCRβ + DN T cells responding in the lungs of mice after LVS i.n. infection expanded to become a large population highly enriched for MAIT cells with characteristic expression of the invariant Vα19-Jα33 TCR α-chain and TCR Vβ6/Vβ8-chains.
We next performed a detailed characterization of the temporal responses of MAIT cells in the lungs of mice during sublethal i.n. infection with LVS. TCRβ + DN T cells were present in only marginally detectable numbers in the lungs of naive mice, but began to expand during the early (day 8) and intermediate (day 10) stages of infection ( Fig. 2 A and B) . Growth of LVS in the lungs of WT mice following sublethal i.n. infection is provided in Fig. 2C for comparison; LVS numbers increased steadily in the lungs until approximately day 8 after inoculation, followed by a continuous reduction in bacterial numbers thereafter. Interestingly, MAIT cells reached peak expansion in the late clearance phase of infection (day 14), and remained a notable presence in the lungs even after clearance of the bacteria (day 18; Fig. 2 A and B) . In contrast, only small numbers of TCRβ ), which lack MAIT cells (7, 8) (Fig. 2 A and B) . Analyses of the levels of expression of Vα19-Jα33 transcripts in total lung cells harvested from WT mice after LVS i.n. infection confirmed the response kinetics of MAIT cells, whereas Vα19-Jα33 transcripts were undetectable in the lungs of LVS-infected MR1 −/− mice (Fig. 2D) . These combined data demonstrate that the vast majority of TCRβ + DN T cells present in the lungs of mice after i.n. infection of LVS are MAIT cells, and further demonstrate that MAIT cells appear relatively early during the course of infection and reach peak expansion in the late clearance stage of infection.
MAIT Cells Preferentially Accumulate in the Lungs During i.n. LVS Infection. Because LVS pulmonary infection is initiated in the lungs but quickly spreads systemically to a variety of organs (including the liver and spleen), we next sought to determine whether MAIT cells circulate to other organs and lymph nodes during i.n. infection of LVS. We monitored the presence of the TCRβ + DN T cell population in the lungs, livers, spleens, mediastinal lymph nodes, and mesenteric lymph nodes in WT mice on day 14 after a sublethal i.n. infection of LVS, at a time when MAIT cells reached maximal numbers in the lungs of infected WT mice (Fig. 2 A and B) . We included LVS-infected MR1 −/− mice in the analysis to differentiate MAIT cells from other T cell types that might be present in the TCRβ + DN T cell population. Total TCRβ + T cells were examined by flow cytometry in the aforementioned tissues and lymph nodes, and total single-cell suspensions harvested from these tissues were assessed for Vα19-Jα33 transcripts by qPCR (Fig. 3 A and B) . As expected, although TCRβ + DN T cells could be detected at low frequencies in various organs and lymph nodes from MR1 −/− mice (Fig. 3A) , they exhibited undetectable levels of Vα19-Jα33 transcripts, confirming that the low numbers of TCRβ + DN T cells present in MR1 −/− mice are not MAIT cells. Among the organs and lymph nodes examined in LVS-infected WT mice, the lungs displayed the highest abundance of MAIT cells, with a large TCRβ + DN T-cell population (∼21% of all CD45 + TCRβ + cells) that was highly reduced in MR1 −/− mice (Fig. 3A) , and high levels of Vα19-Jα33 transcripts (Fig. 3B) . Interestingly, livers from LVS-infected WT mice displayed the second highest abundance of MAIT cells, as determined by flow cytometry and Vα19-Jα33 qPCR ( Fig. 3 A and B) . In contrast, although detectable, MAIT cells represented a much smaller population in the spleens, mediastinal lymph nodes, and mesenteric lymph nodes on day 14 after LVS i.n. infection ( Fig. 3 A and B) . Further analyses of the large MAIT cell population present in the lungs on day 14 after infection revealed a cell surface phenotype indicative of trafficking under inflammatory conditions, including a high proportion of cells expressing CCR2, CXCR3, and CCR5, as well as the integrin α4β1, which has previously been shown to mediate T-cell infiltration into the lungs ( Fig. S1 ) (26, 27) . This MAIT cell phenotype was similar to conventional CD4 + and CD8 + T cells present in the lungs on day 14 (Table  S1 ). Only a small proportion of αβTCR + DN T cells expressed the NK markers NK1.1, CD49b, and Ly49d (Fig. S1 ). However, consistent with human MAIT cells, a large proportion of lung murine MAIT cells were IL-18 receptor α-positive (91.1%) (8, 17) . Overall, these data demonstrate that, despite the systemic spread of LVS pulmonary infection, MAIT cells preferentially accumulated at the initial site of infection, and expressed cell surface receptors in the lungs consistent with inflammatory recruitment.
MAIT Cells Are Essential for Full Resistance to F. tularensis LVS i.n.
Infection. To investigate the ability of MAIT cells to contribute to in vivo protective immune responses during mucosal infection, we compared the course of a primary pulmonary sublethal LVS i.n. infection in the lungs of WT and MR1 −/− mice ( Fig. 4A ).
LVS-infected MR1
−/− mice exhibited significantly higher bacterial burdens in the lungs compared with WT mice, beginning on day 10 after infection ( −/− mice remained significantly higher (on average greater than two log 10 cfus among experiments, with a maximal 580-fold higher cfu count in the MR1 −/− mice on day 13) than LVS-infected WT mice throughout the course of the infection, and clearance of the bacteria from the lungs of MR1 −/− mice was significantly delayed compared with WT mice (Fig. 4A) . Interestingly, no significant defect was observed in bacterial clearance from the spleens and livers of LVS-infected MR1 −/− mice (Fig. S2) . Thus, MAIT cells have a nonredundant role in controlling bacterial burdens in the lungs during LVS i.n. infection.
To assess the role of MAIT cells in the generation of mucosal immune responses, we examined the expression of a range of critical antibacterial mediators in the lungs of WT and MR1 −/− mice during sublethal LVS i.n. infection. Specifically, we assessed production of IFN-γ, IL-17A, TNF, and inducible NO synthase (iNOS), which are essential for host defense against LVS infection (28) (29) (30) .
−/− mice exhibited impaired production of IFN-γ, IL-17A, TNF, and iNOS transcripts in their lungs compared with LVS-infected WT mice; peak production of all four immune mediators was delayed in MR1 −/− mice (day 14) compared with WT mice (day 8; Fig. 4 B-E). Thus, in the absence of MAIT cells, MR1 −/− mice had a defect in production of four critical antimicrobial mediators during the early stages of infection. The impaired cytokine and iNOS responses in MR1 −/− mice corresponded with the observation that MR1 − /− mice exhibited higher bacterial burdens and delayed clearance compared with WT mice (Fig. 4A) . Overall, these data indicate that, in the absence of MAIT cells, initiation of protective immune responses in the lungs of infected mice was delayed during LVS i.n. infection.
MAIT Cells Produce Critical Antibacterial Cytokines in the Lungs During
F. tularensis LVS i.n. Infection. We next assessed the ability of MAIT cells to directly contribute to the reduction of LVS bacterial burdens in the lungs by production of critical cytokines. Previous evidence has established that T-cell production of IFN-γ and TNF limits LVS bacterial growth in macrophages (31, 32) . Therefore, to evaluate the antibacterial capacity of MAIT cells in the lungs of mice during sublethal LVS i.n. infection, we analyzed their production of IFN-γ and TNF, as well as another important mucosal mediator, IL-17A. MAIT cells were purified from the lungs of LVS-infected WT mice by FACS as described in Fig. 1 , and their cytokine production was assessed by qPCR analyses. The results show that, on day 8 after infection, MAIT cells robustly produced IFN-γ, TNF, and IL-17A (Fig. 5A ). MAIT cells also contributed to the production of these three important cytokines during the intermediate phase of infection, as assessed by intracellular cytokine staining (day 10; Fig. 5B ). In contrast, because of their lack of MAIT cells, LVS-infected MR1 −/− mice had only minimal numbers of cytokine-producing TCRβ + DN T cells in the lungs after i.n. infection of LVS (Fig. 5B) . Interestingly, on day 14 after infection, when adaptive CD4 + and CD8 + T cells actively produced cytokines, MAIT cells remained strong producers of IFN-γ and TNF (Fig. 5C ). These in vivo data demonstrate that MAIT cells are significant contributors to antimicrobial cytokine production in the lungs throughout the course of pulmonary LVS infection. To investigate the ability of MAIT cells to use these antimicrobial cytokines to control the intracellular growth of LVS, we used an in vitro macrophage intracellular growth assay. Bone marrow-derived macrophages (BMMØs) were infected with LVS and cocultured with MAIT cells. As a source of MAIT cells, we enriched total Thy1.2 + T cells from naive mice transgenic for the canonical MAIT cell Vα19-Jα33 invariant TCR α-chain (Vα19iTgMR1 +/+ mice), which have a high frequency of MAIT cells (25) . Growth of LVS in the BMMØ monolayer was assessed after 3 d of coculture. Naive MAIT cells resulted in greater than 95% reduction of LVS growth in BMMØs compared with cultures lacking MAIT cells (Fig. 6A) . Addition of a blocking anti-MR1 Ab to the cocultures completely reversed this control of growth (Fig. 6A) . Thus, naive MAIT cells were capable of directly controlling LVS growth in macrophages in a manner that required interaction with their cognate antigen, MR1. Similar results were observed for enriched DN Vα19iTg-MR1 +/+ MAIT cells (Fig. S3A) . Of note, naive T cells harvested from MR1-deficient Vα19iTg mice (Vα19iTgMR1 −/− ) had no impact on LVS growth in BMMØs (Fig. S3A) , revealing that MR1 is required during in vivo development for the innate capacity of the Vα19-Jα33-expressing transgenic T cells to control LVS intracellular growth.
To further investigate the mechanisms by which MAIT cells control LVS intracellular growth in macrophages, we assessed macrophage viability, cytokine production, and nitric oxide (NO) or nitrite levels in the cocultures. Macrophage viability in cocultures containing naive Vα19iTgMR1 +/+ MAIT cells was not significantly diminished compared with control uninfected macrophage cultures (Fig. S3B) . In contrast, cocultures that exhibited unrestricted LVS intramacrophage growth (containing naive Vα19iTgMR1
−/− T cells or no T cells) displayed significant decreases in macrophage viability by the 72-h time point. Overall, these data indicate that MAIT cells do not significantly rely upon induction of macrophage cell death to limit LVS replication in this coculture system. Macrophage-activating cytokines such as IFN-γ and TNF were readily detectable in the 72-h coculture supernatants, in addition to IL-17A and nitrite; production of all these mediators was significantly inhibited by the presence of anti-MR1 Ab in the cocultures (Fig. 6 B-E) . Addition of neutralizing antibodies for IL-12 40 kDa subunit (IL-12p40), TNF, and IFN-γ to the cocultures completely reversed MAIT cell control of bacterial growth, whereas addition of a neutralizing anti-IL-17A antibody had no effect on growth control of LVS by MAIT cells (Fig. 6A) . The addition of the iNOS inhibitor N G -monomethyl arginine (NMMA) to the cultures also completely reversed MAIT control of LVS growth (Fig. 6A) . In addition, blockade of IL-12p40 also inhibited production of IFN-γ, TNF, and NO, but not IL-17A, in the cocultures (Fig. 6) . Further, coculture of LVS-infected IL-12p40
BMMØs with MAIT cells revealed that macrophage IL-12p40 is required for MAIT cells to obtain the capacity to control LVS growth (Fig. S3C) . Thus, naive MAIT cells required cognate MR1 and soluble IL-12p40 signals from infected macrophages to control LVS intramacrophage growth. Finally, MAIT cells used a mechanism of macrophage activation that involved IFN-γ, TNF, and NO production to effect LVS growth control. mice were significantly lower than those of WT mice (Fig. 7A) FACS-sorted from the lungs of WT mice on day 8 after LVS i.n. infection expressed only negligible levels of Vα19-Jα33 chain transcripts (Fig. S4) . Importantly, further investigation of the quality of the TCRβ + CD4 + and CD8 + T cells in the lungs of MR1 −/− mice revealed that the number of activated CD4 + and CD8 + T cells (characterized by CD69 + CD44 hi ) was significantly diminished compared with WT mice at days 8 and 10 after infection ( Fig. 7 B and C) . This resulted in ∼80% and 60% reductions in activated CD4
+ T cells present in total lung cells of MR1 −/− mice on days 8 and 10 after infection, respectively; and an ∼60% reduction in activated CD8 + T cells on both days. Similarly, diminished levels of effector CD62L lo TCRβ + CD4 + and CD8 + T cells were observed in the lungs of infected MR1 −/− mice (Fig. 7B) . Notably, the numbers of activated CD4 + and CD8 + T cells present in the lungs of MR1 −/− mice on day 8 after infection were not significantly different from uninfected animals (Fig. 7C) . Finally, the numbers of IFN-γ-producing TCRβ + CD4
+ cells and CD8 + T cells in the lungs of MR1 −/− mice were 10-fold lower than in WT mice at day 8 after infection, and approximately threefold lower than in WT mice at day 10 after infection ( Fig. 7 B and E) . To determine whether this defect in the recruitment of activated T cells was a permanent deficiency, we investigated the presence of activated CD4 + and CD8 + T cells in infected mice at a later time point (day 14). By day 14 after i.n. infection of LVS, the numbers of activated (CD69 + CD44 hi ), and IFN-γ-producing CD4 + and CD8 + T cells had increased in MR1 −/− mice to either equal (in the case of CD8 + T cells) or exceed (in the case of CD4 + T cells) those of WT mice ( Fig. 7 C and D) −/− mice. Consistent with previous studies, CD4 + CD8 + -depleted WT mice developed a chronic infection and remained alive after 2 mo of infection ( Fig. 8 B and C) . In striking contrast, CD4
−/− mice showed significantly higher burdens of LVS in the lungs than their WT counterparts, and ultimately died at the same time as LVSinfected TCRα −/− mice that lack all αβ T cells (Table 1 and Fig.  8C ). Altogether, these results demonstrate that MAIT cells have the capacity to function long-term to sustain control of LVS growth in the absence of CD4 + and CD8 + T cells.
Discussion
The in vivo evidence presented in the present study demonstrated that MAIT cells actively contributed to immune responses throughout the innate and adaptive phases of primary pulmonary infection with F. tularensis LVS. During the early innate phase of infection, MAIT cells were required for prompt production of proinflammatory cytokines and timely recruitment of activated CD4 + and CD8 + T cells in the lungs. Later during infection, when conventional CD4 + and CD8 + T cells were active, MAIT cells continued to accumulate in the lungs of infected mice and produced important cytokines such as IFN-γ, suggesting an ongoing role for MAIT cells during the adaptive phase of infection.
Here we found that MAIT cells were a small population in the lungs of naive mice that expanded ∼25-fold following LVS i.n. infection, ultimately comprising as much as 20% to 25% of all αβT cells in infected lungs. Interestingly, the kinetics of MAIT cell expansion appear different from other TCRαβ + innate T cell subsets; MAIT cell numbers increased gradually and peaked during the later phases of infection, when CD4 + and CD8 + T-cell responses were also maximal. These observations contrast with the rapid kinetics of other nonconventional TCRαβ + innate T cells. For instance, CD1d-restricted iNKT cells expanded and contracted rapidly during M. bovis bacillus Calmette-Guérin infection, before the peak of conventional T-cell responses (4) . Similarly, the IFN-γ-producing function of iNKT cells was limited to the early phases of Streptococcus pneumoniae infection in vivo, and H2-M3-restricted T cells were early effectors that peaked in numbers before the adaptive phase of Listeria monocytogenes infection (1, 5, 36) . Notably, iNKT cells exhibit an effector/memory phenotype in the periphery of humans and naive mice that requires up-regulation of the transcription factor PLZF during thymic selection (37) . In contrast, MAIT cells do not acquire PLZF expression or an effector/ memory phenotype during thymic development (38, 39) . Thus, MAIT and iNKT cells undergo different developmental programs that may contribute to their differential patterns of expansion or recruitment to infection loci. Interestingly, MAIT cells and iNKT cells appear to have different relationships with commensal microbes. Murine MAIT cells are not found in the periphery of germ-free mice, but expand after reconstitution with commensal bacterial strains (7, 8) . Human MAIT cells acquire a memory phenotype in the periphery after birth, a developmental step thought to result from exposure to commensal microbes (38) . In contrast, increased numbers of iNKT cells accumulated in the colons and lungs of germ-free mice, a phenomenon that was reversed by reconstitution of commensal bacteria in neonates (40) . Here, the characterization of MAIT cell expansion in pulmonary LVS infection provides evidence that MAIT cells may be programmed to have intrinsically different responses from other innate T cells, including iNKT cells.
The rapid contraction of iNKT cells before the peak of conventional T-cell responses during microbial infections in mice has been attributed to apoptosis, a phenomenon proposed to result from sharing of survival cytokines between iNKT cells and conventional T cells (4, 36) . From the data presented here, it is clear that MAIT cell numbers in the lungs during LVS infection were not limited by the expansion and recruitment of classical MHC-restricted T cells, nor did MAIT cells lose functional capacity later in infection, as measured by their continued cytokine production. Interestingly, recent evidence indicates that the apoptotic propensity of human peripheral MAIT and iNKT cells is partially dependent on the balance between expression of proapoptotic proteins (including PLZF) and the antiapoptotic factor X-linked inhibitor of apoptosis (XIAP) (41) . In light of the results presented in our murine model, it is possible that MAIT and iNKT cells possess different apoptotic sensitivities during infectious assaults. An enduring high number of MAIT cells at the initial site of infection could serve as an extended defense mechanism to augment adaptive immune responses and aid in prevention of further pathogen assaults. Of note, the kinetics of human MAIT and iNKT cell responses during infectious diseases are not well defined as a result of the limitations of obtaining patient samples throughout infection. Although both cell types have been detected in lesions of chronically infected patients, their long-term functional capacities in these tissues remain uncertain (17, 18, 42) .
Although T-cell-deficient mice are highly susceptible to LVS infection (33, 43) , it has previously been noted that mice deficient for either CD4 + or CD8 + T cells readily survived sublethal infection, a phenomenon that was attributed to the capacity of each T cell subset to compensate for the absence of the other. However, the data presented here indicated that MAIT cells are another T-cell subset that actively contributes to defense against infection. To assess the potency of MAIT cell activities during infection, we evaluated their ability to provide long-term control of an in vivo sublethal LVS pulmonary infection in the absence of CD4 + and CD8 + T cells. We found that MAIT cells are essential for survival of mice simultaneously depleted of CD4 + and CD8 + T cells during LVS pulmonary infection. Importantly, in the absence of CD4 + and CD8 + T cells, MAIT cell activities in the lungs were sufficient to control, but not clear, LVS infection. Because MAIT cells possessed the capacity to produce critical cytokines such as TNF, IFN-γ, and IL-17A throughout LVS infection, their inability to fully eradicate the bacteria presents an intriguing question. MAIT cells may lack a critical, yet-undefined antimicrobial mechanism, or their tissue tropism may limit their capacity to eliminate a systemic infection. Regardless, our study provides in vivo evidence that MAIT cells can mediate long-term control of a pathogenic infection in the absence of conventional CD4 + and CD8 + T cells. Interestingly, MAIT cells in patients with chronic HIV infection became exhausted and depleted in the circulation, but were relatively preserved in the rectal mucosa (44, 45) . Thus, it is possible that MAIT cells are retained in mucosal tissues as a first line of defense during HIV infection. Our observation that MAIT cells can control bacterial infection in the absence of CD4 + and CD8 + T cells may provide a basis for future studies on the capacity of MAIT cells to provide immunity in an immunocompromised host.
Recent evidence has shown that human MAIT cells uniquely recognize vitamin B metabolites presented by MR1. In particular, intermediates of the vitamin B2 (i.e., riboflavin) biosynthetic pathway bind MR1 and activate human MAIT cells to produce IFN-γ and TNF (16) . Thus far, microbes capable of activating MAIT cells possess the riboflavin biosynthesis pathway, whereas nonactivating microbes do not. In accordance with our in vitro data demonstrating MR1-dependent activation of murine MAIT cells by LVS, F. tularensis also possesses the enzymatic pathway that generates MR1-binding riboflavin precursors. Interestingly, although M. bovis bacillus Calmette-Guérin similarly has the pathway for vitamin B synthesis, murine MAIT cells responded to bacillus Calmette-Guérin-infected macrophages in an MR1-independent manner, instead relying on the noncognate signal IL-12p40 (19) . Similar to iNKT cells, it is possible that MR1 dependence is influenced by the relative strengths of the TCRmediated signal vs. the IL-12 signal (5, 46) . Because LVS is a relatively fast-growing organism that replicates in the cytoplasm (47), whereas M. bovis bacillus Calmette-Guérin is slowgrowing and interferes with endocytic trafficking to replicate in an early endosome (48) , the different intracellular lifestyles of these two bacteria may impact the availability of ligands for loading onto MR1.
Data presented in this study demonstrate that MAIT cells have an essential role in the timely initiation of adaptive immune responses during infection. Recruitment of activated IFN-γ-producing CD4 + and CD8 + T cells was significantly delayed in the lungs of MR1 −/− mice; activated T cell numbers in MR1 −/− mice peaked 2 to 4 d later than WT mice and were accompanied by higher bacterial burdens in the lungs. We similarly observed a lag in the production of TNF, IFN-γ, IL-17A, and iNOS transcripts in the lungs of infected MR1 −/− mice compared with WT mice, providing further evidence that MAIT cells participate in early events that initiate protective immune responses. Consistent with our findings, previous evidence has demonstrated that MR1
−/− mice exhibited transiently higher bacterial burdens in the lungs in the early phase of M. bovis bacillus CalmetteGuérin pulmonary infection compared with WT mice (19) . Similarly, K. pneumoniae-infected MR1 −/− mice displayed transiently higher bacterial growth within 2 d of i.p. infection (20) . Given the evidence provided here, it is likely that MR1-dependent initiation of immune responses during infection is a process that may be common to multiple bacterial pathogens. The precise mechanisms used by MAIT cells to initiate early adaptive immune responses remain undefined. For iNKT cells, their extremely early production of IFN-γ and/or other cytokines is thought to influence other innate immune cells and the progression of adaptive immune responses (49) (50) (51) . In vitro and in vivo evidence provided here demonstrate that MAIT cells produce critical cytokines such as IFN-γ, TNF, and IL-17A in response to LVS infection-all important for initiating adaptive immunity (29, 52) , and controlling LVS growth (53) .
The generation of optimal protective immunity to intracellular pathogens is dependent on the timely and efficient responses of Mice were treated with anti-CD4 and anti-CD8 Abs twice weekly before, and throughout F. tularensis LVS i.n. infection.
Mice were observed for a total of 75 d. This experiment is representative of three experiments of similar design. *P > 0.05 vs. LVS-infected TCRα −/− mice.
CD4 + and CD8 + T cells. Here we show that MAIT cells are required for early cytokine production and prompt recruitment of activated CD4 + and CD8 + T cells to the lungs following pulmonary infection with the intracellular bacterial pathogen F. tularensis LVS. Further, we show that MAIT cells not only have an early role in the initiation of immune responses in the lung, but also actively produce important cytokines during the later phases of infection. Given the abundance of MAIT cells in humans, coupled with their capacity to function at mucosal surfaces during multiple stages of the immune response, the contribution of MAIT cells to immunity should be considered during the development of mucosal vaccines against human pathogens.
Materials and Methods
Bacteria. F. tularensis LVS (no. 29684; American Type Culture Collection) was grown and frozen as previously described (31) . Viable bacteria were quantified by plating serial dilutions on supplemented Mueller-Hinton agar (MHA) plates.
Animals, Infections, and Determination of Bacterial Organ Burdens. Male and female specific pathogen-free C57BL/6J mice were purchased from Jackson Laboratory. MR1-deficient mice (7) Numbers of cfus in organs from infected mice were determined using groups of five mice. The cfu counts in lungs of infected mice were assessed by plating organ homogenates on MHA plates containing an antibiotic mixture to suppress growth of adventitious agents (colistin sulfate salt, lincomycin hydrochloride, trimethoprim, and ampicillin).
Preparation of Single-Cell Suspensions from Organs. To prepare lung cells for RNA extraction and/or flow cytometry, the lungs were excised following perfusion through the right heart ventricle with a solution of DMEM containing 2% (vol/vol) FBS, collagenase (0.72 mg/mL), and DNase (10 U/mL). Harvested lungs were subjected to pressure disruption, followed by incubation for 20 min at 37°C in 5% CO 2 . Released cells were filtered through a Filtra-bag (Lab Plas), subjected to ammonium chloride/potassium lysis, and passed through a 40-μm filter. Liver cells were prepared by pressure disruption of whole livers followed by centrifugation for 20 min at 500 × g on a 40%/80% (wt/vol) Percoll gradient to separate leukocytes from cell debris and epithelial cells. Spleen cells, mediastinal lymph nodes, and mesenteric lymph nodes were prepared by pressure disruption and ammonium chloride/ potassium lysis and passed through a 40-μm filter to remove debris. In all cases, live cells prepared from tissues were enumerated on a hemocytometer after dilution in trypan blue. To monitor the expression of TNF, IFN-γ, and IL-17A, lung cells were incubated in complete Dulbecco's modified eagle medium (cDMEM) containing 5 μg/mL Brefeldin A at 37°C in 5% CO 2 for 4 h (without additional exogenous stimulation, as cell preparations also contained live bacteria from the in vivo infection), and stained for cell surface markers. Intracellular staining was performed by using the BD Biosciences buffer system according to the manufacturer's instructions. For flow sorting experiments, lung cells from LVS-infected mice were stained with the appropriate cell surface markers, and sorted directly into Qiagen RNA Protect for RNA extraction and quantitative real-time RT-PCR. Sorting of DN T cells was performed by selecting cells negative for CD4, CD8, γδTCR, and B220, but positive for TCRβ. Cells positive for TCRβ and CD4, or TCRβ and CD8, were sorted for analyses of CD4 + and CD8 + T-cell gene expression.
RNA Extraction and Quantitative Real-Time RT-PCR. Total RNA was prepared using RNeasy Mini Kit (Qiagen), and first-strand cDNA was synthesized using the Retroscript Kit (Ambion) according to the manufacturer's instructions. Real-time PCR was performed by using the ABI Prism ViiA7 instrument (Applied Biosystems). Cytokine and iNOS transcripts were quantified by using TaqMan Predeveloped Assay Kits (Applied Biosystems) according to the manufacturer's instructions. Assessment of expression of Vα19-Jα33 and Vα14-Jα18 transcripts was performed by quantitative real-time PCR using previously described primer-probe pairs (10) , and the results were normalized to expression of the TCRα constant chain.
Culture and Infection of BMMØ with Bacteria. Bone marrow macrophages were used as the target cells for the in vitro system. BMMØs were cultured as previously described (31) . Cells were plated at 4 × 10 5 in 96-well plates in cDMEM supplemented with 50 μg/mL gentamycin (Life Technologies) and incubated at 37°C in 5% CO 2 . After 1 d, the medium was replaced with antibiotic-free cDMEM, and the cells were incubated for an additional 6 d at 37°C in 5% CO 2 . The medium was replaced with fresh, gentamycin-free cDMEM every 2 d during the 7-d incubation. Following the 7-d culture period, the BMMØ concentration was estimated to be 2 × 10 6 cells per well.
BMMØ were then infected with F. tularensis LVS at a multiplicity of infection of 1:10 (bacterium-to-BMMØ ratio). LVS was coincubated with BMMØs at 37°C in 5% CO 2 for 2 h and then washed three times with PBS solution (Life Technologies). The monolayers were incubated for 1 h in cDMEM supplemented with 50 μg/mL gentamicin to eliminate extracellular bacteria. The BMMØ were washed a further three times with PBS solution, followed by addition of cDMEM and purified splenocytes at a ratio of one purified T cell per two macrophages. The cells were cocultured at 37°C in 5% CO 2 for 3 d before lysis to determine bacterial growth. Vα19iTgMR1 +/+ mice were used as source of naive splenic total Thy1. Quantitation of Cytokines and NO in BMMØ Culture Supernatants. Culture supernatants were assayed for cytokines by cytometric bead array (BD Pharmingen) and quantified by comparison with recombinant standards. NO was detected in culture supernatants by the Griess reaction by using commercial Griess reagent (Sigma).
Statistical Analyses. All experiments were performed with three to five mice per experimental group, and repeated at least twice to assess reproducibility.
Differences between the means of experimental groups were analyzed by using the two-tailed Student t test; P values of 0.05 or less were considered significant.
